At Bio-Asia Taiwan 2026, the Italian Trade Agency (ITA) is proud to showcase ExoLab Italia within the Italian Pavilion as a prime example of the nation's cutting-edge scientific capabilities. This science-driven biotech scale-up, has its foundations deeply rooted in over 30 years of pioneering scientific research conducted at the prestigious Italian National Institute of Health (ISS). Backed by ITA's mission to bridge international commercial sectors, ExoLab successfully connects advanced institutional science with market-ready applications, positioning itself as a unique innovator in the global biotechnology landscape.

The company's core strength lies in combining patented scientific know-how with a highly sustainable, eco-friendly industrial process designed to isolate and produce its proprietary Plant-Derived Extracellular Vesicles (PDEV) platform technology directly from organic plant sources. Functioning as powerful natural delivery systems, these plant-derived vesicles offer unparalleled stability, biocompatibility, and cellular absorption. This manufacturing approach allows ExoLab to deliver scalable, chemical-free solutions that meet the surging global demand for clean, safe, and highly efficient bio-based compounds.

Under ITA’s framework of fostering bilateral biotechnology partnerships, ExoLab strategically pursues a high-growth dual market approach. The company currently serves the nutraceutical and cosmetic sectors, providing premium active ingredients that enhance anti-aging, cellular regeneration, and wellness formulations. Concurrently, it is rapidly advancing its biotechnological research into medical fields, focusing on breakthrough drug delivery systems and precision health applications to redefine the future of tailored medical therapies and intelligent skincare on a global scale.

ExoLab

ExoLab Italia is a science-driven biotech scale-up at the forefront of cellular innovation, specializing in the development of a proprietary Plant-Derived Extracellular Vesicles (PDEV) platform technology. The company’s foundations are rooted in academic excellence, built on more than 30 years of pioneering scientific research generated at the prestigious Italian National Institute of Health (ISS). By bridging advanced institutional science with market-ready commercial applications, ExoLab has positioned itself as a unique player in the international biotechnology landscape.

The company successfully combines patented scientific know-how with a highly sustainable, eco-friendly industrial process designed to isolate and produce premium bioactive ingredients directly from organic plant sources. These plant-derived vesicles function as powerful natural delivery systems, offering unparalleled stability, biocompatibility, and cellular absorption. This innovative manufacturing approach allows ExoLab to deliver scalable, chemical-free solutions that meet the growing global demand for clean, safe, and highly efficient bio-based compounds.

Currently, ExoLab strategically serves the high-growth nutraceutical and cosmetic sectors, providing premium active ingredients that enhance anti-aging, cellular regeneration, and overall wellness formulations. Concurrently, the company is rapidly advancing its biotechnological research into medical fields, focusing on breakthrough drug delivery systems and precision health applications. Through these targeted efforts, ExoLab Italia aims to redefine the future of tailored medical therapies and intelligent skincare on a global scale.